Cutaneous hyperpigmentation following bleomycin sclerotherapy for vascular malformations

被引：6

作者：

Davis, Kyle P. ^{[1
]}

Gaffey, Megan M. ^{[1
,2
,3
]}

Kompelli, Anvesh R. ^{[1
]}

Richter, Gresham T. ^{[1
,2
]}

机构：

[1] Univ Arkansas Med Sci, Dept Otolaryngol Head & Neck Surg, Little Rock, AR 72205 USA

[2] Arkansas Childrens Hosp, Div Pediat Otolaryngol, 800 Marshall St, Little Rock, AR 72202 USA

[3] NYU, Langone Hlth, Div Pediat Otolaryngol, Dept Otolaryngol Head & Neck Surg, New York, NY USA

来源：

PEDIATRIC DERMATOLOGY | 2022年 / 39卷 / 01期

关键词：

bleomycin; hyperpigmentation; sclerotherapy; vascular malformations; ANESTHESIA;

D O I：

10.1111/pde.14869

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Systemic bleomycin therapy is associated with pulmonary fibrosis and cutaneous side effects. While it is believed that there is little to no systemic distribution of bleomycin when utilized to treat vascular malformations (VMs), we present a case series in which cutaneous, adhesive-related hyperpigmentation suggests that there is systemic egress of bleomycin following direct puncture sclerotherapy (DPS). This risk of hyperpigmentation after intralesional bleomycin should be discussed with patients, and steps to minimize the chances of it occurring should be implemented.

引用

页码：103 / 106

页数：4

共 50 条

[21] Pycnogenol ® prevents skin hyperpigmentation following sclerotherapy [J].

Cesarone, Maria R. ;

Belcaro, Gianni ;

Cox, David ;

Scipione, Valeria ;

Scipione, Claudia ;

Dugall, Mark ;

Cornelli, Umberto ;

Hosoi, Morio ;

Feragalli, Beatrice ;

Hu, Shu ;

Cotellese, Roberto .

MINERVA SURGERY, 2024, 79 (02) :161-165

[22] Sclerotherapy with bleomycin versus surgical excision for extracervical cystic lymphatic malformations in children [J].

Burak Ardıçlı ;

İbrahim Karnak ;

Arbay Ö. Çiftçi ;

F. Cahit Tanyel ;

M. Emin Şenocak .

Surgery Today, 2016, 46 :97-101

[23] Sclerotherapy with bleomycin versus surgical excision for extracervical cystic lymphatic malformations in children [J].

Ardicli, Burak ;

Karnak, Ibrahim ;

Ciftci, Arbay O. ;

Tanyel, F. Cahit ;

Senocak, M. Emin .

SURGERY TODAY, 2016, 46 (01) :97-101

[24] PERCUTANEOUS TREATMENT OF FACIAL VENOUS MALFORMATIONS: A MATCHED COMPARISON OF ALCOHOL AND BLEOMYCIN SCLEROTHERAPY [J].

Spence, Jessica ;

Krings, Timo ;

TerBrugge, Karel G. ;

Agid, Ronit .

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2011, 33 (01) :125-130

[25] HYPERPIGMENTATION INDUCED BY BLEOMYCIN [J].

ALBIG, J ;

GOLLNICK, H ;

DETMAR, M ;

ORFANOS, CE .

HAUTARZT, 1992, 43 (06) :376-379

[26] Bleomycin electrosclerotherapy: new treatment to manage vascular malformations [J].

McMorrow, L. ;

Shaikh, M. ;

Kessell, G. ;

Muir, T. .

BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2017, 55 (09) :977-979

[27] Sclerotherapy as an esthetic indication in oral vascular malformations: a case series [J].

Manzano, Brena Rodrigues ;

Premoli, Aloizio Maciel ;

Santaella, Natalia Garcia ;

Sanomiya Ikuta, Carla Renata ;

Fisher Rubira, Cassia Maria ;

da Silva Santos, Paulo Sergio .

ANAIS BRASILEIROS DE DERMATOLOGIA, 2019, 94 (05) :521-526

[28] The use of foam sclerotherapy for the treatment of head and neck vascular malformations [J].

Rehman, Khaleeq-Ur ;

Sittampalam, Ganeshwaran ;

McCafferty, Ian ;

Monaghan, Andrew .

BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2009, 47 (08) :631-632

[29] Image-Guided Percutaneous Bleomycin and Bevacizumab Sclerotherapy of Orbital Lymphatic Malformations in Children [J].

Omar Abdelaziz ;

Farouk Hassan ;

Kareem Elessawy ;

Sally Emad-Eldin ;

Rania El Essawy .

CardioVascular and Interventional Radiology, 2019, 42 :433-440

[30] Clinical outcomes and predictors of bleomycin polidocanol foam sclerotherapy treatment response in venous malformations [J].

Ni, Bin ;

Liu, Jing-wen ;

Fan, Xue-qiang ;

He, Bin ;

Nie, Qiang-qiang ;

Ye, Zhi-dong ;

Liu, Peng ;

Wen, Jian-yan .

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2024, 52 (01)

← 1 2 3 4 5 →